MAJI (Exousia Pro) FCF Yield %: 0.00 (As of Jun. 28, 2026)


What is Exousia Pro FCF Yield %?

Exousia Pro MAJI +5.90% FCF Yield % is 0.00 as of Jun. 28, 2026.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Exousia Pro's Trailing 12-Month Free Cash Flow is $-0.00 Mil, and Market Cap is $0.54 Mil. Therefore, Exousia Pro's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Exousia Pro's FCF Yield % or its related term are showing as below:


MAJI's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -9.62
* Ranked among companies with meaningful FCF Yield % only.

Exousia Pro's FCF Margin % for the quarter that ended in Jan. 2021 was 0.00%.

Exousia Pro FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Exousia Pro FCF Yield % Related Terms

Exousia Pro FCF Yield % Historical Data

* Premium members only.

The historical data trend for Exousia Pro's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro FCF Yield % Chart

Exousia Pro Annual Data
Trend Apr11 Apr12 Apr18 Apr19
FCF Yield %
0.00 -4.33 -0.18 -0.90

Exousia Pro Quarterly Data
Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 0.31 -0.19 0.30 -0.38

MAJI vs HCCH, GRNV, AGBA: FCF Yield % Comparison

For the Biotechnology subindustry, Exousia Pro's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exousia Pro FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exousia Pro's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Exousia Pro's FCF Yield % falls into.


Exousia Pro FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Exousia Pro's FCF Yield % for the fiscal year that ended in Apr. 2019 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.009 / 0.99912
=-0.90%

Exousia Pro's annualized FCF Yield % for the quarter that ended in Jan. 2021 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.019 * 4 / 19.7548488
=-0.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 0.00 mean?
Exousia Pro (MAJI) has a FCF Yield % of 0.00 as of Jun. 28, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Exousia Pro and its competitors.
Is Exousia Pro's FCF Yield % too high?
Exousia Pro's current FCF Yield % is 0.00.
How does Exousia Pro's FCF Yield % compare to HCCH and GRNV?
Exousia Pro's FCF Yield % of 0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Exousia Pro and its competitors. Exousia Pro's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exousia Pro stock overvalued right now?
Exousia Pro (MAJI) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Exousia Pro (MAJI), the current FCF Yield % is 0.00 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.